Abstract

Novel Psychoactive Substances (NPS), sometimes referred to as Legal Highs, are newly available drugs with psychoactive properties that are not currently prohibited by United Nations Drug Conventions. Despite many of these compounds still being ‘legal’ and readily available via online mail-order companies and high-street ‘headshops’, their rapid emergence in the UK has been associated with increasing hospital admissions, enquiries on TOXBASE® and fatalities. It is therefore vital that Acute Physicians have a good understanding of the issues in recognizing, investigating and managing patients presenting to the AMU with toxicity due to legal highs. This article outlines the classification and effects of various novel psychoactive substances and presents a strategy for management according to the prevailing toxidrome.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

 

References

1. Home Office (2014). New Psychoactive Substances Review. Report of the expert Panel September 2014. London: Home Office. Available online at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/368583/NPSexpertReviewPanelReport.pdf
2. International Narcotics Control Board (2013). Report of the International Narcotics Control Board for 2013. Available online at: https://www.incb.org/incb/en/publications/annual-reports/annual-report-2013.html
3. European Monitoring Centre for Drugs and Drug Addiction (2015). European Drug Report 2015: Trends and Developments. Lisbon: EMCDDA. Available online at: http://www.emcdda.europa.eu/edr2015
4. Public Health England (2014). National Poisons Information Service (NPIS): Report 2013/14. Available online at: http://www.npis.org/NPISAnnualReport2013-14.pdf
5. Office for National Statistics (2015). Deaths related to drug poisoning in England and Wales, 2014 registrations. London: ONS. Available online at: http://www.ons.gov.uk/ons/dcp171778_414574.pdf